Allergic Fungal Rhinosinusitis and the Unified Airway: the Role of Antifungal Therapy in AFRS
详细信息    查看全文
Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 1999;74(9):877–84. This report coined the term ‘eosinophilic fungal sinusitis’, suggested that most CRS was due to a hypersensitivity to fungal antigens, and launched the current debate regarding fungi in chronic sinus disease.CrossRef PubMed
2.Buzina W, Braun H, Freudenschuss K, et al. Fungal biodiversity-as found in nasal mucus. Med Mycol. 2003;41:149–61.PubMed
3.Safirstein B. Allergic bronchopulmonary aspergillosis with obstruction of the upper respiratory tract. Chest. 1976;70:788–90.CrossRef PubMed
4.••
Katzenstein AL, Sale SR, Greenberger PA. Allergic aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol. 1983;72:89–93. This is the first case series of AFRS cases. Based upon clinical history and histopathologic findings the authors proposed a pathophysiologic mechanism for the disease as well as a treatment paradigm that persists to this day.CrossRef PubMed
5.Manning SC, Holman M. Further evidence for allergic pathophysiology in allergic fungal sinusitis. Laryngoscope. 1998;108(10):1485–96.CrossRef PubMed
6.Allphin AL, Strauss M, Addul-Karin FW, et al. Allergic fungal sinusitis: problems in diagnosis and treatment. Laryngoscope. 1991;101:815–82.CrossRef PubMed
7.Cody DT, Neel HB, Ferreiro JA, et al. Allergic fungal sinusitis: the Mayo Clinic experience. Laryngoscope. 1994;104:1074–9.CrossRef PubMed
8.•
Ferguson BJ. Eosinophilic mucin rhinosinusitis: a distinct clinicopathologic entity. Laryngoscope. 2000;110:799–813. This study demonstrated important clinical difference between AFRS as classically defined and other forms of ‘eosinophilic mucin rhinosinusitis’ such as in aspirin exacerbated respiratory disease.CrossRef PubMed
9.Pant H, Kette FE, Smith WB, et al. Eosinophilic mucus chronic rhinosinusitis: clinical subgroups or a homogeneous pathogenic entity? Laryngoscope. 2006;116:1241–7.CrossRef PubMed
10.Marple BF. Allergic fungal sinusitis: current theories and management strategies. Laryngoscope. 2001;111:1006–19.CrossRef PubMed
11.Stewart AE, Hunsaker DH. Fungus-specific IgG and IgE in allergic fungal rhinosinusitis. Otolaryngol Head Neck Surg. 2002;127:324–32.CrossRef PubMed
12.Erwin GE, Fitzgerald JE. Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole. J Asthma. 2007;44(10):891–5.CrossRef PubMed
13.Braun JJ, Pauli G, Schultz P, et al. Allergic fungal sinusitis associated with allergic bronchopulmonary aspergillosis: an uncommon sinobronchial allergic mycosis. Am J Rhinol. 2007;21(4):412–6.CrossRef PubMed
14.Marple B, Newcomer M, Schwade N, et al. Natural history of allergic fungal sinusitis: a 4- to 10-year follow-up. Otolaryngol Head Neck Surg. 2002;127(5):361–6.CrossRef PubMed
15.Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the infectious diseases society of America. Clin Infect Dis. 2008;46:327–60.CrossRef PubMed
16.Rains BM, Mineck CW. Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol. 2003;17(1):1–8.PubMed
17.Chan KO, Genoway KA, Javer AR. Effectiveness of itraconazole in the management of refractory allergic fungal rhinosinusitis. J Otolaryngol Head Neck Surg. 2008;37(6):870–4.PubMed
18.Seiberling K, Wormald PJ. The role of itraconazole in recalcitrant fungal sinusitis. Am J Rhinol Allergy. 2009;23(3):303–6.CrossRef PubMed
19.Khalil Y, Tharwat A, Abdou AG, et al. The role of antifungal therapy in the prevention of recurrent allergic fungal rhinosinusitis after functional endoscopic sinus surgery: a randomized, controlled study. Ear Nose Throat J. 2011;90(8):E1–7.PubMed
20.Ponikau JU, Sherris DA, Kita H. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2002;110:862–6.CrossRef PubMed
21.Kennedy DW, Kuhn FA, Hamilos DL, et al. Treatment of chronic rhinosinusitis with high-dose oral Terbinafine: a double blind, placebo-controlled study. Laryngoscope. 2005;115(10):1793–9.CrossRef PubMed
22.•
Weschta M, Rimek D, Formanek M, et al. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol. 2004;113(6):1122–8. This randomized trial failed to show any benefit of topical amphotericin B in CRS patients, thus discounting the ‘fungal hypothesis’ for CRS.CrossRef PubMed
23.Weschta M, Rimek D, Formanek M, et al. Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2006;132:743–7.CrossRef PubMed
24.Ponikau JU, Sherris DA, Weaver A, et al. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol. 2005;115(1):125–31.CrossRef PubMed
25.•Ebbens FA, Scadding GK, Badia L, et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2006;118(5):1149–56. This was another robust multicenter randomized trial that failed to show a benefit of topical amphotericin B as a treatment approach for CRS.CrossRef PubMed
26.Liang KL, Su MC, Shiao JY, et al. Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, double-blind study. Am J Rhinol. 2008;22(1):52–8.CrossRef PubMed
27.Gerlinger I, Fittler A, Fónai F, et al. Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy. Eur Arch Otorhinolaryngol. 2009;266(6):847–55.CrossRef PubMed
28.Bent JP 3rd, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg. 1994;111(5):580–8)
  • 作者单位：Matthew W. Ryan (1)
    Christopher M. Clark (1)

    1. Department of Otolaryngology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-9035, USA
  • 刊物主题：Allergology;
  • 出版者：Springer US
  • ISSN：1534-6315
    • 文摘
    Allergic fungal sinusitis (AFS) or rhinosinusitis (AFRS) is a form of polypoid chronic rhinosinusitis that is believed to be due to hypersensitivity to fungal antigens. The disease is characterized by type 1 hypersensitivity to fungal allergens, dramatically elevated total serum IgE, accumulation of thick eosinophil-laden mucin with non-invasive fungal hyphae within the paranasal sinuses, nasal polyposis, and sinus bony remodeling. Because of many clinicopathologic similarities to allergic bronchopulmonary aspergillosis (ABPA), these conditions can be considered analogous examples of disease in the unified airway. However, these conditions rarely occur together and their treatment differs. The treatment of AFRS relies upon surgical removal of fungal hyphae in eosinophilic mucin, while antifungal therapy is used to clear fungi from the airways in ABPA. Several uncontrolled studies suggest there may be some benefit to antifungal agents in AFRS, but randomized trials of topical and systemic antifungal therapies have not shown beneficial results in chronic rhinosinusitis (CRS). Antifungal treatment within the sinonasal cavities does not appear to be an effective approach for most chronic sinusitis, and antifungal therapy for AFRS is unproven.

    © 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

    地址：北京市海淀区学院路29号 邮编：100083

    电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700